Spinocerebellar Ataxias clinical trials
The registry lists 95 studies for Spinocerebellar Ataxias across more than 10 countries. 25 are recruiting or about to start. 57 of them are mainly about Spinocerebellar Ataxias (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 2 narrower conditions too, such as Ataxia Telangiectasia: 151 studies, 30 open.
Get an email when these change. Save the Spinocerebellar Ataxias studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Chang Gung University (5) · University of Florida (4) · Kissei Pharmaceutical Co., Ltd. (4) · Columbia University (4) · Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (3) · Assistance Publique - Hôpitaux de Paris (3) · University of Chicago (3) · Institut National de la Santé Et de la Recherche Médicale, France (3)
What is being tested here
Drugs under test in Spinocerebellar Ataxias studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 8
- Dec 2026Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2 · Arrowhead Pharmaceuticals
- Dec 2026Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases · Mayo Clinic
- Dec 2026Efficacy of Cerebellar Transcranial Magnetic Stimulation to Treat Hereditary Spinocerebellar Ataxias · Xijing Hospital
- Jun 2027Non-invasive Spinal Stimulation for Gait in Genetic Spasticity · University of Washington
- Jun 2027Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia · Sclnow Biotechnology Co., Ltd.
- Jul 2027Gait Analysis in Neurological Disease · Beth Israel Deaconess Medical Center
- Aug 2027Effects of Oral Administration of Antrodia Cinnamomea Products for Clinical Symptoms in Spinocerebellar Ataxia Patients · ALPS Biotech CO. LTD
- Oct 2027Ophthalmological Disorders in Dominant Spinal-cerebellar Ataxias · University Hospital, Montpellier
Who these studies take
Of the 16 Spinocerebellar Ataxias studies recruiting now, 8 (50%) set no upper age limit and 3 (19%) stop at 75 or younger. 4 (25%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 5 (31%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 4 (25%) | 4 (25%) |
| 18 | 11 (69%) | 11 (69%) |
| 30 | 16 (100%) | 16 (100%) |
| 40 | 16 (100%) | 16 (100%) |
| 50 | 16 (100%) | 16 (100%) |
| 65 | 15 (94%) | 15 (94%) |
| 75 | 13 (81%) | 13 (81%) |
| 85 | 12 (75%) | 12 (75%) |
Across all 95 studies, recruiting or not: 35% stop at 75 or younger and 16% at 65; 18% take children; 1% are for women only and 0% for men only; 24% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Spinocerebellar Ataxias studies take
Of 28 interventional studies with no phase under Spinocerebellar Ataxias, half reached primary completion within 21 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 21 mo7–30 · 28 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 15, 2026.
Started recruiting1
- Rare Disease Registry Database for Movement Disorders in Southern Anhui ProvinceOct 23, 2026NCT07838883
Newly registered1
- Non-invasive Spinal Stimulation for Gait in Genetic SpasticityNov 12, 2026NCT07930481
Studies
Recruiting first, then most recently updated. Showing 50 of 95. Browse all 95 → or search them.
- Non-invasive Spinal Stimulation for Gait in Genetic SpasticityEnrolling by invitationNCT07930481Not applicable1 country
- Cerebellar DBS in SCA1 and SCA3 StudyNot yet recruitingNCT07752095Not applicable1 country
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT017931681 country
- Rare Disease Registry Database for Movement Disorders in Southern Anhui ProvinceRecruitingNCT078388831 country
- Multi-Modal Digital Monitoring of Disease Symptoms in Spinocerebellar AtaxiaNot yet recruitingNCT078513761 country
- A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HDRecruitingNCT05822908Phase 1/26 countries
- Natural History Study of and Genetic Modifiers in Spinocerebellar AtaxiasRecruitingNCT010603712 countries
- Autosomal Dominant Spinocerebellar Ataxias and Social CognitionRecruitingNCT07099651Not applicable1 country
- Interposed Nucleus aDBS for AtaxiaRecruitingNCT07325487Not applicable1 country
- Deep Brain Stimulation for Spinocerebellar AtaxiaRecruitingNCT07288437Not applicable1 country
- Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar AtaxiaNot yet recruitingNCT03378414Phase 2
- Expanded Access Protocol of Troriluzole in Patients With Spinocerebellar Ataxia (SCA)AvailableNCT06034886
- Ophthalmological Disorders in Dominant Spinal-cerebellar AtaxiasRecruitingNCT07019558Not applicable1 country
- Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic PathologyRecruitingNCT07136844Not applicable1 country
- Structural Validity and Inter-rater Reliabitiliy of the Ataxia Trunk, Lower And Upper Extremity Scale (ATLAS)Not yet recruitingNCT07079332
- Efficacy of Cerebellar Transcranial Magnetic Stimulation to Treat Hereditary Spinocerebellar AtaxiasNot yet recruitingNCT06898645Not applicable
- Effects of Oral Administration of Antrodia Cinnamomea Products for Clinical Symptoms in Spinocerebellar Ataxia PatientsRecruitingNCT06633003Not applicable1 country
- Cycling-Based Priming Coordination Training for Enhancing Ataxia Recovery and Brain PlasticityRecruitingNCT06600269Not applicable1 country
- Hong Kong Spinocerebellar Ataxias RegistryRecruitingNCT033360081 country
- Stemchymal® for Polyglutamine Spinocerebellar AtaxiaNot yet recruitingNCT06397274Phase 2
- Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide RibosideNot yet recruitingNCT06324877Not applicable1 country
- Electrical Stimulation Cycling Training Effects on SCARecruitingNCT06363058Not applicable1 country
- Biomarker Research in Inherited Movement DisordersRecruitingNCT050341721 country
- rTMS Improves Functions in Spinocerebellar AtaxiaRecruitingNCT05973019Not applicable1 country
- The EUROSCA Natural History StudyRecruitingNCT0244076310 countries
- Troriluzole in Adult Participants With Spinocerebellar AtaxiaCompletedNCT03701399Phase 32 countries
- Natural History of Spinocerebellar Ataxia Type 7 (SCA7)Active, not recruitingNCT027414401 country
- Pivotal Study of N-acetyl-L-leucine for CACNA1AActive, not recruitingNCT07221292Phase 37 countries
- Real-World Data Study of Troriluzole-Treated Patients With Spinocerebellar Ataxia (SCA) Compared to a Matched Natural History ControlCompletedNCT065291461 country
- RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7CompletedNCT010377771 country
- Gait Analysis in Neurological DiseaseActive, not recruitingNCT029947191 country
- Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2Active, not recruitingNCT06672445Phase 18 countries
- MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study)CompletedNCT076016851 country
- Use of a New Smartphone Application to Determine Changes in Eyeblink Conditioning From Home Training in Individuals With Spinocerebellar AtaxiaWithdrawnNCT06177626Not applicable
- Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat DiseasesActive, not recruitingNCT045292521 country
- Wearable Gait SensorsActive, not recruitingNCT066289341 country
- Efficacy of tDCS in Degenerative AtaxiaActive, not recruitingNCT07250321Not applicable1 country
- Integrated Functional Evaluation of the CerebellumCompletedNCT042881281 country
- Trial in Adult Participants With Spinocerebellar Ataxia (SCA)CompletedNCT02960893Phase 2/31 country
- NIPD on CFTC for Triplet Repeat DiseasesCompletedNCT03087526Not applicable1 country
- The Study of Transcranial Magnetic Stimulation in the Regulation of Spinocerebellar AtaxiaActive, not recruitingNCT06904716Not applicable1 country
- Effect of Dapagliflozin Administration on the Apoptosis Levels of Patients with Acute Myocardial InfarctionCompletedNCT06615674Phase 41 country
- Using Real-time fMRI Neurofeedback and Motor Imagery to Enhance Motor Timing and Precision in Cerebellar AtaxiaCompletedNCT05436262Not applicable1 country
- Instrumented Data Exchange for Ataxia StudyCompletedNCT042681471 country
- Open Pilot Trial of BHV-4157Active, not recruitingNCT03408080Phase 31 country
- Priming Motor Learning Through Exercise in People With Spinocerebellar AtaxiaActive, not recruitingNCT05826171Not applicable1 country
- Use of Real-Time Functional Magnetic Resonance Imaging Neurofeedback to Improve Motor Function in Cerebellar AtaxiaCompletedNCT05436249Not applicable1 country
- Could Tai-chi Help Maintain Balance of Spinocerebellar Ataxia PatientsCompletedNCT03687190Not applicable
- Cerebellar Transcranial Direct Current Stimulation in Spinocerebellar Ataxia 38CompletedNCT05951010Not applicable1 country
- Ataxia GAA-FGF14 - Descriptive Genetic and Clinical StudyActive, not recruitingNCT058840861 country